Search Results - "Beekhuizen, Heleen J"

Transabdominal and transvaginal ultrasound findings help to guide the clinical management of placenta accreta spectrum cases by Aryananda, Rozi Aditya, Duvekot, Johannes J., Van Beekhuizen, Heleen J., Cininta, Nareswari Imanadha, Ariani, Grace, Dachlan, Erry Gumilar

“…Introduction The clinical management of placenta accreta spectrum (PAS) depends on placental topography and vascular involvement. Our aim was to determine…”
Get full text

Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study by Schwickert, Alexander, van Beekhuizen, Heleen J, Bertholdt, Charline, Fox, Karin A, Kayem, Gilles, Morel, Olivier, Rijken, Marcus J, Stefanovic, Vedran, Strindfors, Gita, Weichert, Alexander, Weizsaecker, Katharina, Braun, Thorsten

“…Placenta accreta spectrum (PAS) carries a high burden of adverse maternal outcomes, especially significant blood loss, which can be life-threatening. Different…”
Get more information

Prevalence of fetal anomalies, stillbirth, neonatal morbidity, or mortality in pregnancies complicated by placenta accreta spectrum disorders by Viana Pinto, Pedro, Kawka-Paciorkowska, Katarzyna, Morlando, Maddalena, Huras, Hubert, Kołak, Magdalena, Bertholdt, Charline, Jaworowski, Andrzej, Braun, Thorsten, Fox, Karin A, Morel, Olivier, Paping, Alexander, Stefanovic, Vedran, Mhallem, Mina, Van Beekhuizen, Heleen J

“…Placenta accreta spectrum disorders (PAS) lead to major complications in pregnancy. While the maternal morbidity associated with PAS is well known, there is…”
Get full text

Performance of antenatal imaging to predict placenta accreta spectrum degree of severity by Morel, Olivier, van Beekhuizen, Heleen J, Braun, Thorsten, Collins, Sally, Pateisky, Petra, Calda, Pavel, Henrich, Wolfgang, Al Naimi, Ammar, Nikoline Norgaardt, Lone, Chalubinski, Kinga M, Sentilhes, Loic, Tutschek, Boris, Schwickert, Alexander, Stefanovic, Vedran, Bertholdt, Charline

“…In cases of placenta accreta spectrum, a precise antenatal diagnosis of the suspected degree of invasion is essential for the planning of individual management…”
Get more information

A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum by van Beekhuizen, Heleen J, Stefanovic, Vedran, Schwickert, Alexander, Henrich, Wolfgang, Fox, Karin A, MHallem Gziri, Mina, Sentilhes, Loïc, Gronbeck, Lene, Chantraine, Frederic, Morel, Oliver, Bertholdt, Charline, Braun, Thorsten, Rijken, Marcus J, Duvekot, Johannes J

“…Management options for women with placenta accreta spectrum (PAS) comprise termination of pregnancy before the viable gestational age, leaving the placenta in…”
Get more information

Pelvic lymph node dissection for cervical or bladder cancer: embedding residual fat tissue offers no added value by Vaneman, Jasmijn, van Beekhuizen, Heleen J., Boormans, Joost L., Ewing-Graham, Patricia C., van Leenders, Geert J. L. H., Smolders, Ramon G. V., van Doorn, H (Lena) C.

“…Diagnosis of lymph node metastases in pelvic lymph node dissection (PLND) is important for staging and treatment. Standard practice is to submit visible or…”
Get full text

Developing a database for multicenter evaluation of placenta accreta spectrum by Braun, Thorsten, van Beekhuizen, Heleen J, Morlando, Maddalena, Morel, Olivier, Stefanovic, Vedran

“…Studies of rare, but complex clinical conditions require multicenter cooperation. The International Society for Placenta accreta spectrum (IS-PAS) have…”
Get more information

The effects of neutral argon plasma versus electrocoagulation on tissue in advanced-stage ovarian cancer: a case series by Nieuwenhuyzen-de Boer, Gatske M, van de Berg, Nick J, Gao, Xu Shan, Ewing-Graham, Patricia C, van Beekhuizen, Heleen J

“…The aim of surgery for advanced-stage ovarian cancer is a complete cytoreduction, because this is the most important independent prognostic factor for…”
Get full text

Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review by Brons, Puck E, Nieuwenhuyzen-de Boer, Gatske M, Ramakers, Christian, Willemsen, Sten, Kengsakul, Malika, van Beekhuizen, Heleen J

“…Background: The tumor marker ‘cancer antigen 125’ (CA-125) plays a role in the management of women with advanced stage ovarian cancer. This study aims to…”
Get full text

Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: A multinational database study by Morlando, Maddalena, Schwickert, Alexander, Stefanovic, Vedran, Gziri, Mina M, Pateisky, Petra, Chalubinski, Kinga M, Nonnenmacher, Andreas, Morel, Olivier, Braun, Thorsten, Bertholdt, Charline, Van Beekhuizen, Heleen J, Collins, Sally L

“…Placenta accreta spectrum (PAS) is a condition often resulting in severe maternal morbidity. Scheduled delivery by an experienced team has been shown to…”
Get more information

Relevance of routine pathology review in cervical carcinoma by van Beekhuizen, Heleen J., Freulings, Mieloe D., Dasgupta, Shatavisha, van Kemenade, Folkert J., Ewing-Graham, Patricia C., van Doorn, Helena C.

“…To determine the impact of pathology review on the management of patients with cervical carcinoma, 264 reports of pathology review from 230 patients referred…”
Get full text

Single-dose compared with multiple day antibiotic prophylaxis for cesarean section in low-resource settings, a randomized controlled, noninferiority trial by Westen, Esther H M N, Kolk, Pascal R, van Velzen, Christine L, Unkels, Regine, Mmuni, Nicholaus S, Hamisi, Alex D, Nakua, Ritha E, Vlek, Anne L M, van Beekhuizen, Heleen J

“…To investigate the efficacy of a single prophylactic dose of ampicillin combined with metronidazole to prevent postcesarean section infections compared with a…”
Get more information

Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix by Salarzaei, Morteza, van de Laar, Ralf L O, Ewing-Graham, Patricia C, Najjary, Shiva, van Esch, Edith, van Beekhuizen, Heleen J, Mustafa, Dana A M

“…This study aims to refine our understanding of the inherent heterogeneity in cervical cancer by exploring differential gene expression profiles, immune cell…”
Get full text

Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational study by van Doorn, Helena C, Oonk, Maaike H M, Fons, Guus, Gaarenstroom, Katja N, de Hullu, Joanne, van Rosmalen, Joost, van Beekhuizen, Heleen J

“…Standard groin treatment in recurrent vulvar cancer consists of uni- or bilateral inguinofemoral lymphadenectomy (IFL), whereas in the primary setting women…”
Get full text

Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis by Kengsakul, Malika, Nieuwenhuyzen-de Boer, Gatske M, Udomkarnjananun, Suwasin, Kerr, Stephen J, Niehot, Christa D, van Beekhuizen, Heleen J

“…Advances in ovarian cancer cytoreductive surgery have enabled more extensive procedures to achieve maximal cytoreduction but with a consequent increase in…”
Get full text

Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions by Abdulrahman, Ziena, Hendriks, Natasja, J Kruse, Arnold, Somarakis, Antonios, J M van de Sande, Anna, J van Beekhuizen, Heleen, M J Piek, Jurgen, de Miranda, Noel F C C, Kooreman, Loes F S, F M Slangen, Brigitte, van der Burg, Sjoerd H, de Vos van Steenwijk, Peggy J, van Esch, Edith M G

“…BackgroundThe complete response rate of cervical high-grade squamous intraepithelial lesion (cHSIL) patients to imiquimod immunotherapy is approximately 60%…”
Get full text

Identifying Molecular Changes in Early Cervical Cancer Samples of Patients That Developed Metastasis by de Geus, Vera, Ewing-Graham, Patricia C, de Koning, Willem, de Koning, Maurits N C, van den Bosch, Thierry P P, Nigg, Alex L, van Eijck, Casper H J, Jozwiak, Marta, van Beekhuizen, Heleen J, Mustafa, Dana A M

“…Cervical cancer is one of the most common cancers in women worldwide. Patients diagnosed with early-stage cervical cancer have a good prognosis, however,…”
Get full text

Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review by Nieuwenhuyzen-de Boer, Gatske M, van der Kooy, Jacoba, van Beekhuizen, Heleen J

“…About 80 % of all women affected by ovarian cancer present with advanced stage disease at the time of diagnosis. Achieving complete cytoreduction is…”
Get full text

Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia – A case series by Wouters, Tirza, Hendriks, Natasja, Koeneman, Margot, Kruse, Arnold-Jan, van de Sande, Anna, van Beekhuizen, Heleen J., Gerestein, Kees G., Bekkers, Ruud L.M., Piek, Jurgen M.J.

“…Treatment for cervical intraepithelial neoplasia (CIN) often consists of an excisional procedure. However, less invasive treatment methods have been explored,…”
Get full text

Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis by Steenbeek, Miranda P, van Bommel, Majke H D, Bulten, Johan, Hulsmann, Julia A, Bogaerts, Joep, Garcia, Christine, Cun, Han T, Lu, Karen H, van Beekhuizen, Heleen J, Minig, Lucas, Gaarenstroom, Katja N, Nobbenhuis, Marielle, Krajc, Mateja, Rudaitis, Vilius, Norquist, Barbara M, Swisher, Elizabeth M, Mourits, Marian J E, Massuger, Leon F A G, Hoogerbrugge, Nicoline, Hermens, Rosella P M G, IntHout, Joanna, de Hullu, Joanne A

“…After risk-reducing salpingo-oophorectomy (RRSO), / pathogenic variant (PV) carriers have a residual risk to develop peritoneal carcinomatosis (PC). The…”
Get full text